Quisqualate selectively inhibits a brain peptidase which cleaves N-acetyl-L-aspartyl-L-glutamate in vitro.
Quisqualate selectively inhibits a brain peptidase which cleaves N-acetyl-L-aspartyl-L-glutamate in vitro.
复制标题
Quisqualate 选择性抑制脑肽酶,该酶可在体外裂解 N-乙酰基-L-天冬氨酰-L-谷氨酸。
DOI:
10.1016/0014-2999(86)90291-8
复制
发表时间:
1986
影响因子:
5
通讯作者:
Coyle,JT
中科院分区:
文献类型:
--
作者:
Robinson,MB;Blakely,RD;Coyle,JT
The endogenous brain peptide, N-acetyl-L-aspartyl-L-glutamate (NAAG), has been proposed as an excitatory neurotransmitter (Coyle et al., in press). Electrophysiological, immunocytochemical, and lesion studies support this role in the lateral olfactory tract (ffrench-Mullen et al., 1985; Blakely et al., 1986), a putative glutamatergic pathway. The rapid termination of the excitatory action of iontophoretically applied NAAG suggests that mechanism (s) other than diffusion likely account for its inactivation. We have previously demonstrated that, during incubation of synaptosomes with [3H] NAAG, glutamate (Glu) derived from the carboxy-terminus of NAAG is actively sequestered by synaptosomes while N-acetyl-L-aspartate (NAA), the other cleavage product, is apparently not transported (Blakely et al., 1986b). Transport of radiolabelled Glu derived from NAAG is inhibited with similar potency by many compounds that effectively block Na+-dependent, high affinity Glu uptake (SDHAGU). One striking difference between the pharmacological profiles of these two transport processes is a high sensitivity of the former process to L-quisqualate (Quis), a rather ineffective inhibitor of SDHAGU. To explain these observations, we postulated the existence of a peptidase activity, associated with